By Robb M. Stewart
Insulet Corp. mentioned Monday U.S. regulators have cleared its tubeless automated insulin supply system for people aged two years and older with sort 1 diabetes.
With Meals and Drug Administration clearance of the Omni pod 5 Automated Insulin Supply System, healthcare professionals can now prescribe Omnipod 5 to their sufferers with insurance coverage protection and sufferers can entry their prescription by the pharmacy channel, which suggests there is no such thing as a contract and no dedication, Insulet mentioned. The Omnipod model is the one insulin pump within the U.S. out there by the pharmacy, the corporate mentioned.
Omnipod 5 was initially cleared to be used in people aged six and older in January.
Insulet’s shares closed Friday at $267.42, up 0.5% thus far this yr however down 9.4% over the previous 12 months.
Write to Robb M. Stewart at [email protected]
